Glancy Prongay Drops Out Of Blood Drug Lead Counsel Race
By Ryan Harroff · March 21, 2023, 4:44 PM EDT
Glancy Prongay & Murray withdrew its bid to serve as lead counsel in a proposed class action brought against an Israeli biotech company accused of misleading its investors, stating that after...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login